Donate to RSRT then cruise around the OC with Jocelyn's Uncle Steve! The ride will start and end at Uncle Steve's home March 11, 2017.
On February 9th, 2010 the Jones family discovered Jocelyn, only 21 months at the time, has Rett Syndrome. Rett is a neurological disorder that strikes at random and affects almost exclusively girls. It can be described as symptoms of autism, cerebral palsy, Parkinson’s, epilepsy, and anxiety... all in one little girl! Jocelyn requires total 24-hour-a-day care, most debilitating is that she cannot walk or talk, and has no purposeful use of her hands.
BUT WAIT, THERE IS HOPE!!! In 2007, Dr. Bird dramatically reversed symptoms in a Rett mouse model! A cure is in Jocelyn’s future, as scientists have continuously described, “Rett is positioned to be the first REVERSIBLE neurological disorder”.
Jocelyn's Uncle, Steve, is going to ride around the OC to help fundraise for Rett Research and to help speed the path towards a cure.
Learn more about Jocelyn on her website: www.jocelynsjourney.org
What is Rett Syndrome?
Rett Syndrome is serious lifelong neurological disorder that is caused by random mutations in a gene called MECP2. Diagnosed almost exclusively in girls, symptoms typically appear in toddlerhood. Many children with Rett are unable to speak, walk or use their hands. Breathing problems, feeding tubes, seizures, anxiety, gastrointestinal and orthopedic issues are common.
Despite the debilitating nature of the disorder our girls are so much more than a laundry list of symptoms. Their beauty and their strength inspire and motivate us.
Rett Syndrome stands apart from other neurological disorders due to the dramatic reversibility of symptoms in animal models. Our confidence that Rett Syndrome is curable guides our every decision.
Who is RSRT?
The Rett Syndrome Research Trust (RSRT) was launched in 2008 with a singular goal: to drive the development of treatments and cures for Rett Syndrome and related MECP2 disorders. As one of the few neurological disorders to demonstrate dramatic symptom reversal in the lab, Rett Syndrome has captured the attention of the world’s premiere university and pharmaceutical industry scientists. RSRT is operating at the nexus of this activity, leading and advancing the research agenda.
By funding the most Rett research worldwide, $35 million since 2008, we strive to put ourselves out of business as soon as possible.